Institutional investors purchased a net $6.7 million shares of TENX during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 10.77% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 254.2 Thousand shares of Tenax Therapeutics Inc